Federal award
BIOFIRE DIAGNOSTICS LLC
W91YTZ21F0148
Contract
Obligated and Ceiling
- Obligated (net)
- $291,521.26
- Ceiling (potential value, not spending)
- $291,521.26
- Current value
- $291,521.26
- Gross positive obligations
- $328,922.55
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOFIRE DIAGNOSTICS LLC · TBBNREFT3LD3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BIOFIRE DIAGNOSTICS LLC · E449GWZZN225
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTZ
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ21F0148
- Parent vehicle (IDV PIID)
- V797D30085
- Award type code
- C
- Actions
- 7 · Jun 3, 2021 to Mar 8, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 8, 2024 | FY2024 | P00006 | C | −$57.07 | — |
| Oct 4, 2023 | FY2024 | P00005 | D | −$37,344.22 | — |
| Jun 12, 2023 | FY2023 | P00004 | C | $109,640.85 | — |
| Jun 9, 2023 | FY2023 | P00003 | G | $0.00 | — |
| May 13, 2022 | FY2022 | P00002 | G | $109,640.85 | — |
| Jun 24, 2021 | FY2021 | P00001 | M | $0.00 | — |
| Jun 3, 2021 | FY2021 | 0 | — | $109,640.85 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.